Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Nucor Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while Nucor Corporation trades at $257.14 (market cap $58.33B). The key difference: Nucor Corporation is the larger of the two by market cap, and Nucor Corporation pays the higher dividend (0.87%). Which is the better fit depends on your goals.
| GEHC | NUE | |
|---|---|---|
Market Cap | $30.93B | $58.33B |
Volume | 5,033,451 | 1,032,707 |
Sector | Health | Basic Materials |
52-Week High | $88.16 | $274.74 |
52-Week Low | $59.48 | $131.78 |
Enterprise Value | $39.39B | $62.74B |
Dividend Yield | 0.23% | 0.87% |
Typical Hold Time | — | 78 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Nucor (NUE) trades at $253.80, up 0.78% on the day, with a bullish technical signal driven by moving averages and near-term resistance at $254. The stock has shown strong earnings momentum, beating estimates in two of the last three quarters, with Q3 2026 guidance projecting higher earnings. Revenue trends are improving, with 2026 revenue forecast at $36.1B, and the company maintains a solid balance sheet with a debt-to-asset ratio of 20.23% as of 2025. Analyst consensus is a 'Buy' with a $266.88 price target, reflecting optimism around steel pricing and operational execution.
The outlook for NUE is positive, supported by earnings beats, favorable steel market dynamics, and a shareholder-friendly dividend policy. Key risks include competitive pressures from new capacity, volatility in steel prices, and macroeconomic sensitivity. The stock offers upside to consensus targets but requires monitoring of cost pressures and industry supply changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
